PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events. Can Cardiol Today [Internet]. 19 mars 2025 [cité 29 mars 2026];1(1):20–25. Disponible à: https://canadiancardiologytoday.com/article/view/1-1-Abramson_et_al